DRUGS

作品数:1566被引量:4032H指数:27
导出分析报告
相关作者:狄晴余年张燕芳蒋莉蔡方成更多>>
相关机构:北京大学重庆医科大学沈阳药科大学四川大学华西医院更多>>
相关期刊:更多>>
相关基金:国家自然科学基金国家重点基础研究发展计划中国博士后科学基金北京市自然科学基金更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 期刊=Chinese Medical Journalx
条 记 录,以下是1-10
视图:
排序:
Chinese expert consensus on clinical application of molecularly targeted drugs for hepatocellular carcinoma(2022 edition)
《Chinese Medical Journal》2024年第21期2630-2632,共3页Juxian Sun Qiu Li Xueli Bai Jianqiang Cai Yajin Chen Minshan Chen Chaoliu Dai Chihua Fang Weidong Jia Xiangcheng Li Tianfu Wen Jinglin Xia Mingang Ying Zhiwei Zhang Xuewen Zhang Zhaochong Zeng Shuqun Cheng On behalf of Chinese Association of Liver Cancer and Chinese Medical Doctor Association 
supported by grants from the State Key Project of the National Natural Science Foundation of China(No.81730097);the Clinical Science and Technology Innovation Project of Shanghai Shenkang Hospital Development Center(Joint Project of Emerging Frontier Technology)(No.SHDC12018116);the Clinical Research Plan of Shanghai Hospital Development Center(No.SHDC2020CR1004A).
To the Editor:Primary liver cancer is one of the most common malignant tumors in China.In 2020,410,038 new cases of liver cancer and 391,152 deaths due to liver cancer were reported in China,which places liver cancer ...
关键词:HEPATOCELLULAR DRUGS cancer 
Mechanism and clinical efficacy of peripheral blood alive cell treatment on androgenic alopecia
《Chinese Medical Journal》2024年第20期2507-2508,共2页Zigang Zhao Xin Zhang Xiaoyan Qu Yaguang Zhou Shui Yu Qinyi Wang Qian Zhang 
supported by grants from the Natural Science Foundation of Hainan Province(No.820MS123);the Guangdong Enterprise Joint Fund(No.2022A1515220137);the Shenzhen Science and Technology Innovation Committee(No.JCYJ20220530141615035).
To the Editor:Androgenic alopecia(AGA)is a common chronic hair loss disorder that usually begins in adolescence,with hair follicle miniaturization.[1]Clinical manifestations include reduced hair diameter and volume,po...
关键词:CLINICAL DRUGS TREATMENT 
Chinese expert consensus on the application of immune checkpoint inhibitors in liver transplantation for hepatocellular carcinoma
《Chinese Medical Journal》2024年第18期2143-2145,共3页Zhengxin Wang Jiayin Yang Guangming Li 
funded by the National Key Research and Development Program of China(Nos.2021YFA1100500 and 2023YFC2505900);National Natural Science Foundation of China(Nos.81873874,82071797,and 82241225);Beijing Natural Science Foundation(No.7222096)
Primary liver cancer(PLC)is the fourth-most common malignancy and second leading cause of tumor-related deaths in China.Hepatocellular carcinoma(HCC)accounts for 75-85%of PLCs.[1]At present,radical surgery remains the...
关键词:DRUGS treatment EXCEEDING 
Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features
《Chinese Medical Journal》2024年第13期1620-1622,共3页Hesong Zou Wei Liu Yi Wang Dandan Shan Ting Xie Ru Li Huimin Liu Wenyang Huang Mingwei Fu Tingyu Wang Rui Lyu Shuhui Deng Weiwei Sui Yan Xu Shuhua Yi Gang An Lugui Qiu Dehui Zou 
CAMS Innovation Fund for Medical Sciences(Nos.CIFMS 2022-I2M-1-022 and 2020-I2M-C&T-B-085)
To the Editor:Diffuse large B-cell lymphoma(DLBCL)exhibits clinical significance and biological diversity.Over the last two decades,rituximab with cyclophosphamide,doxorubicin,vincristine,and prednisone(R-CHOP)has sub...
关键词:CHOP DRUGS CHEMOTHERAPY 
Endocrine therapy of short duration prevents local and contralateral recurrence of ductal carcinoma in situ of the breast:A multicenter retrospective cohort study in China
《Chinese Medical Journal》2024年第14期1756-1758,共3页Zhen Wang Zining Jin Huanrui Zhang Guiying Xu Dianlong Zhang Fengqi Fang Hua Xing Jia Wang Baoliang Guo Guolian Zhu Yongzhi Liu Jieqing Li Zhengang Cai Liang Sun Yuting Zhang Tianyang Zhou Chang Liu Baosen Zhou Feng Jin Yan Zhang Dong Song Bo Chen 
funded by grants from the 2023 Applied Basic research project of Liaoning province(No.2023JH2/101300048 to B.Chen);2021 Science and Technology project of Shenyang(No.21-173-9-07 to G.Zhu).
To the Editor:De-escalating the treatment of ductal carcinoma in situ(DCIS)of the breast has been investigated in recent years.A 5-year adjuvant endocrine therapy(AET)regimen is the recommended treatment for hormone r...
关键词:REGIMEN BREAST DRUGS 
Ferroptosis:A therapeutic opportunity of inflammatory bowel disease
《Chinese Medical Journal》2024年第7期874-876,共3页Yulin Ye Limin Liu Yang Jing Shuangzhe Yao Mo Yang Xin Dai Meiyu Piao Xin Xu Zelin Feng Xiaoli Wang Yifei Liu Junming Miao Xingjie Gao Qingxiang Yu Xiaocang Cao 
National Natural Science Foundation of China(Nos.82270565 and 82100565);Scientific research project of Tianjin Municipal Commission of Education(No.2022KJ243)
To the Editor:Even to this day,the etiology and pathogenesis of inammatory bowel disease(IBD)are still unelucidated.Despite signicant progress in IBD treatment in recent years,some patients remain insensitive or non-r...
关键词:DRUGS DEATH TREATMENT 
New progress of small-molecule drugs in the treatment of inflammatory bowel disease
《Chinese Medical Journal》2024年第5期556-558,共3页Dongying Yao Zhihua Ran 
With the advent of small-molecule drugs,treatment of inflammatory bowel disease(IBD)has reached a new stage.In contrast to biologics,small-molecule drugs can be made into oral dosage forms with a short half-life and a...
关键词:DRUGS TREATMENT INFLAMMATORY 
Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer(2022 edition)
《Chinese Medical Journal》2023年第24期2909-2911,共3页Qinghua Meng Zhengqiang Yang Zhenyu Zhu Juan Li Xinyu Bi Xiao Chen Chunyi Hao Zhen Huang Fei Li Xiao Li Guangming Li Yinmo Yang Yefan Zhang Haitao Zhao Hong Zhao Xu Zhu Jiye Zhu Jianqiang Cai The Liver Tumor Branch of the China International Exchange and Promotive Association for Medical and Healthcare(CPAM) The Gastrointestinal Cancer Multidisciplinary Cooperation Group of Cancer Hospital Chinese Academy of Medical Sciences&Peking Union Medical College The Liver Cancer Professional Committee of Chinese Medical Doctor Association 
Introduction Primary liver cancer is a significant health issue in China,where it ranks fourth in morbidity and second in mortality among all malignant tumors.[1-4]The 5-year overall survival rate of Chinese patients ...
关键词:DRUGS INFUSION eliminate 
Interaction between OCT1 and LPIN1 polymorphisms and response to pioglitazone-metformin tablets in patients with polycystic ovary syndrome
《Chinese Medical Journal》2023年第14期1756-1758,共3页Haixia Zeng Yanting Huang Dengke Liu Tianqin Xie Zheng Chen Qiulan Huang Xiaojun Zhou Xiaoyang Lai Jianping Liu 
To the Editor:Polycystic ovary syndrome(PCOS)is a common endocrine disorder among women of reproductive age.PCOS is characterized by infrequent or absent ovulation,high androgen levels,and hyperinsulinaemia.Androgenic...
关键词:TABLETS AZONE DRUGS 
Expert consensus on the use of human serum albumin in adult cardiac surgery被引量:3
《Chinese Medical Journal》2023年第10期1135-1143,共9页Fei Xiang Fuhua Huang Jiapeng Huang Xin Li Nianguo Dong Yingbin Xiao Qiang Zhao Liqiong Xiao Haitao Zhang CuiZhang Zhaoyun Cheng Liangwan Chen Jimei Chen Huishan Wang Yingqiang Guo Nan Liu Zhe Luo Xiaotong Hou Bingyang Ji Rong Zhao Zhenxiao Jin Robert Savage Yang Zhao Zhe Zheng Xin Chen on behalf of Chinese Association of Cardiovascular Surgeons Chinese Society of Thoracic and Cardiovascular Surgery Chinese Society of Cardiothoracic and Vascular Anesthesiology 
Introduction Albumin,which is a 65-kDa liver-synthesized protein,accounts for nearly 50%of total plasma protein and contributes to approximately 80%of intravascular oncotic pressure.Albumin helps maintain microvascula...
关键词:ALBUMIN DRUGS SURGERY 
检索报告 对象比较 聚类工具 使用帮助 返回顶部